Viagra-maker Viatris beats Q2 estimates on branded and generic drug…
Aug 8 (Reuters) – Drugmaker Viatris beat second-quarter profit and revenue estimates on Thursday, driven by strong demand for 비아그라 정품 the Viagra-maker’s off-patent branded and generic drugs. Shares of the company were up 3.6% in premarket trade. The Canonsburg, Pennsylvania-based company also raised the 2024 sales outlook for its new product range, including Breyna …